Lower vs standard insulin dose for high potassium in ER
Part of Hormones & metabolism clinical trials.
This study compares a lower dose versus a standard dose of insulin and dextrose (sugar water) to treat moderately high potassium levels in emergency department patients. It aims to see if a lower dose works just as well with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and in the emergency department.
- Your blood potassium level must be between 5.7 and 6.4 mmol/L (from a non-clotted sample).
- You cannot have diabetic ketoacidosis or a hyperosmolar hyperglycemic state (very high blood sugar emergencies).
- Your blood sugar before treatment must be at least 4 mmol/L.
- You must not need emergency treatments like IV insulin, nebulized albuterol, or IV sodium bicarbonate at the time of screening.
- You must be stable (not needing resuscitation, high-flow oxygen, or having a high early warning score).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether relaxing the usual potassium restrictions in your diet is safe and helpful for people on hemodialysis. It may allow you to eat more foods you enjoy while keeping your potassium at a safe level.
This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.
This study tests if careful potassium management can help people with chronic kidney disease (CKD) safely take higher doses of blood pressure medicines called ACE inhibitors or ARBs, which are known to protect the kidneys. You may be eligible if you have moderate to advanced CKD and are already on a moderate dose of one of these medications.
This trial tests a new drug called WS016 to lower high potassium levels in adults. High potassium can be dangerous for your heart, and this study aims to find out if WS016 is safe and effective.
This study tests a medicine called patiromer, which helps lower high potassium levels in the blood. It is for children under 12 who have high potassium that needs treatment for at least a month.
This study compares two medicines, spironolactone and finerenone, to see which one manages potassium levels better in people with heart failure, type 2 diabetes, and kidney disease. Participants have high potassium levels, and the trial aims to find a safer way to manage this.
Hear when a new Hyperkalemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.